Nida Ali, MD
Rheumatology · Sacramento
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 19 years
- Graduated 2007
Offices
2 locations · Regents of the Univ of CA · Telemedicine Group PC
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Ali’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A156233 · Current
Licensed to practise in California · since 2018 · expires 2028-06-30 · University of Karachi, Dow Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
- American Board of Internal Medicine - Rheumatology
Original Medicare doctor bills
$5,587
Medicare paid this office $5,587 for 49 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 21 | $2,125 | $89 |
| Long return visit (40+ min) | 11 | $1,563 | $120 |
Who their Medicare patients are
49 Original Medicare patients in 2024. Average age 70 · Women 76% · Also on Medicaid 37% · Health risk score 2.03. Sicker patients than 9 in 10 peers; the typical rheumatology clinician is at 1.38.
Conditions among them: High blood pressure 73% · Coronary heart disease 31% · Diabetes 29% · Depression 27% · Chronic kidney disease 24% · Heart failure 22%.
The office billed $33,101, Medicare allowed $9,052 and paid $5,587; for 68 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 49 | 68 | 70 | 2.03 | $33,101 | $5,587 |
| 2023 | 77 | 174 | 70 | 1.67 | $88,093 | $18,173 |
| 2020 | 69 | 157 | 74 | 3.03 | $64,913 | $14,852 |
| 2019 | 356 | 982 | 73 | 2.76 | $357,299 | $83,828 |
| 2018 | 43 | 114 | 71 | 3.23 | $37,586 | $8,834 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Long return visit (40+ min) | 24 | $4,744 | $148 |
| Return visit (30+ min) | 27 | $4,276 | $102 |
| New patient visit (60+ min) | 20 | $3,229 | $161 |
| New patient visit (45+ min) | 21 | $2,606 | $124 |
2020: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 28 | $5,332 | $81 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $3,866 | $168 |
| Hospital discharge day management, more than 30 minutes | 22 | $2,058 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,143 | $60 |
2019: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 144 | $27,817 | $83 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 154 | $18,635 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 106 | $17,449 | $162 |
| Hospital discharge day management, more than 30 minutes | 141 | $12,439 | $87 |
| Initial hospital observation care per day, typically 70 minutes | 13 | $1,964 | $151 |
2018: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $4,065 | $57 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $1,980 | $165 |
| Hospital discharge day management, more than 30 minutes | 12 | $1,061 | $88 |
Medicaid work
$58 in 2024
Medicaid paid $58 for 76 billed services this clinician did in 2024, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Telehealth transmission, per minute, professional services bill separately | 76 | $58 |
| 2024 | 76 | 1 | 17 | $58 |
| 2020 | 50 | 2 | 15 | $681 |
| 2019 | 274 | 4 | 27 | $2,881 |
| 2018 | 54 | 1 | 18 | $1,087 |
See the largest Medicaid services in earlier years
2020
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 27 | $453 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 23 | $228 |
2019
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 134 | $1,312 |
| 1ST HOSP IP/OBS HIGH 75 | 39 | $677 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 61 | $491 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 40 | $401 |
2018
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 54 | $1,087 |
Drugs they prescribed that Part D paid
$419,400
Pharmacies billed $419,400 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 135) in 2024. At or below the middle of the specialty; the typical rheumatology clinician is at 3%.
65 generic and 70 brand-name prescriptions · $419,400 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Enbrel Sureclick | 11 | $80,624 | $7,329 |
| Hydroxychloroquine Sulfate | 19 | $955 | $50 |
| Prednisone | 28 | $233 | $8 |
Year by year
| 2024 | 135 | 33 | 0% (0) | 52% | $419,400 |
| 2023 | 154 | 36 | 0% (0) | 19% | $209,391 |
| 2022 | 138 | 61 | 0% (0) | 20% | $133,917 |
| 2021 | 118 | 29 | 0% (0) | 18% | $86,160 |
| 2020 | 95 | 42 | None | None | $29,403 |
| 2019 | 359 | 117 | 6% (22) | None | $24,202 |
| 2018 | 97 | 43 | None | 11% | $2,611 |
| 2017 | 85 | 45 | None | 24% | $4,930 |
| 2016 | 57 | 25 | None | None | $3,328 |
| 2015 | 15 | None | None | None | $1,249 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Hydroxychloroquine Sulfate | 17 | $1,252 | $74 |
| Prednisone | 46 | $503 | $11 |
| Methotrexate | 15 | $311 | $21 |
2022: 4 drugs
| Humira(Cf) | 15 | $100,939 | $6,729 |
| Hydroxychloroquine Sulfate | 26 | $1,171 | $45 |
| Methotrexate | 24 | $766 | $32 |
| Prednisone | 25 | $323 | $13 |
2021: 3 drugs
| Hydroxychloroquine Sulfate | 31 | $2,372 | $77 |
| Methotrexate | 27 | $1,463 | $54 |
| Prednisone | 17 | $167 | $10 |
2019: 6 drugs
| Amoxicillin-Clavulanate Potass | 27 | $305 | $11 |
| Atorvastatin | 21 | $189 | $9 |
| Prednisone | 18 | $94 | $5 |
| Azithromycin | 11 | $83 | $8 |
| Hydrocodone-Acetaminophen | 17 | $68 | $4 |
| Furosemide | 14 | $57 | $4 |
Money from drug and device companies
$40 in 2025
| 2025 | 1 | 2 | None | $40 |
| 2024 | 1 | 1 | None | $19 |
| 2023 | 1 | 1 | None | $98 |
| 2022 | 1 | 1 | None | $100 |
| 2021 | 1 | 1 | None | $99 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Alinity | $40 | 2 payments
|
See all 2 published payments
| Abbott Laboratories | Meals · 2025-06-17 | Alinity | $14 |
| Abbott Laboratories | Meals · 2025-06-17 | Alinity | $26 |
See earlier years (2024, 2023, 2022, 2021)
2024: $19
| Sobi | Kineret | $19 | 1 payment
|
2023: $98
| Janssen Biotech | Tremfya | $98 | 1 payment
|
2022: $100
| Janssen Biotech | Tremfya | $100 | 1 payment
|
2021: $99
| Janssen Biotech | Tremfya | $99 | 1 payment
|
Professional record
- NPI
- 1881075646
- Licence
- CA A156233, MO 2015015417California A156233: Current · expires 2028-06-30
- Group
- Regents of the Univ of CA · Telemedicine Group PC
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RR0500X (207RR0500X); Internal medicine (207R00000X); Hospitalist (208M00000X)
- Mailing address
- 2315 Stockton Blvd, Sacramento, CA, 95817
- NPI first listed
- 2015-06-17
- NPI last updated
- 2020-07-23
- NPI record certified
- 2020-07-23
This is when the NPI record was last certified, not a medical board exam.